Literature DB >> 31737327

Is local consolidative therapy adequate for the treatment of oligometastatic non-small cell lung cancer?

Taichiro Goto1.   

Abstract

Entities:  

Year:  2019        PMID： 31737327      PMCID： PMC6837952          DOI： 10.21037/jtd.2019.09.80

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

Review 1.  Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review.

Authors:  L Spelt; B Andersson; J Nilsson; R Andersson
Journal:  Eur J Surg Oncol       Date:  2011-11-12       Impact factor: 4.424

Review 2.  Advances in local and ablative treatment of oligometastasis in prostate cancer.

Authors:  Henry Hi Yao; Matthew Kh Hong; Niall M Corcoran; Shankar Siva; Farshad Foroudi
Journal:  Asia Pac J Clin Oncol       Date:  2014-08-25       Impact factor: 2.601

3.  Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.

Authors:  Izabela Łasińska; Tomasz Kolenda; Anna Teresiak; Katarzyna M Lamperska; Łukasz Galus; Jacek Mackiewicz
Journal:  Anticancer Agents Med Chem       Date:  2019       Impact factor: 2.505

Review 4.  The oligometastatic state - separating truth from wishful thinking.

Authors:  David A Palma; Joseph K Salama; Simon S Lo; Suresh Senan; Tom Treasure; Ramaswamy Govindan; Ralph Weichselbaum
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

5.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

6.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

7.  Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients.

Authors:  C Collen; N Christian; D Schallier; M Meysman; M Duchateau; G Storme; M De Ridder
Journal:  Ann Oncol       Date:  2014-08-11       Impact factor: 32.976

8.  Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).

Authors:  Dirk De Ruysscher; Rinus Wanders; Angela van Baardwijk; Anne-Marie C Dingemans; Bart Reymen; Ruud Houben; Gerben Bootsma; Cordula Pitz; Linda van Eijsden; Wiel Geraedts; Brigitta G Baumert; Philippe Lambin
Journal:  J Thorac Oncol       Date:  2012-10       Impact factor: 15.609

9.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

10.  Lymph node cancer of the mediastinum with a putative necrotic primary lesion in the lung: a case report.

Authors:  Daichi Shikata; Takahiro Nakagomi; Rumi Higuchi; Yujiro Yokoyama; Toshio Oyama; Taichiro Goto
Journal:  World J Surg Oncol       Date:  2018-04-02       Impact factor: 2.754
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.